Emma’s comments on Cancer Recovery Guide

Dear Jonathan

I just want to say a huge thank-you for all your help and advice.I also want  to say how inspirational your book and all its suggestions have been. It has enabled me to keep positive for my sister over the past terrible months. I just hope I can get her to follow some of your recommendations!

Emma Greener

Townsend letter for Doctors Review

The Townsend Letter for Doctors is the pre-eminent voice of alternative medicine in the world. So naturally I am cock-a-hoop over the following book review of my book Cancer Recovery Guide: 15 Alternative and Complementary Strategies for Restoring Health.

http://www.townsendletter.com/AugSept2008/bookreviewDrc0808.htm

The reviewer was Jonathan Collin, MD and the review appeared under the headline: 2008 Best Guide to Alternative Cancer Therapies?

So here it is:

Jonathan Chamberlain is not a physician, and that may be all the better when it comes to writing a guide to alternative cancer therapies. He is a good writer and avoids slathering on the medical jargon that makes most health books arcane or tedious. Most lay folks enter the field of cancer either by getting cancer or taking care of a loved one with cancer, and Chamberlain was no exception. In his case, his wife prematurely developed cancer, and she dutifully attended the medical clinic in London undergoing surgery, radiation treatment, and chemotherapy. She apparently had an aggressive tumor, and none of the treatments effectively abated the progression of the disease. Within a year, she was dead, and Chamberlain was distraught, not only with the outcome of her disease but with the sheer ineffectiveness of the treatment she was offered. Hence, Chamberlain was inspired to explore the cancer field and study its ways.

For a book shorter than 200 pages, with big print, Chamberlain’s Cancer Recovery Guide packs a lot of discussion on theory and treatment into what may be the best read on alternative therapies for cancer. He previously published a much larger book, Cancer: The Complete Recovery Guide, as an e-book (2007, www.fightingcancer.com), which discusses the therapies in much greater depth. Yet the shorter Cancer Recovery Guide covers alternative and complementary therapies with enough information to interest readers in the therapies and encourage their use. In just a few pages, Chamberlain offers a great comeback argument for the hardcore health professionals and the cynical journalists who dispute that alternative therapies play any legitimate role in treating cancer. Indeed, the worried and disbelieving family members who attempt to dissuade any participation with alternative medicine would have great difficulty debating Chamberlain’s discussion except to offer the same tired quip that, “if the alternative method was good treatment, then your oncologist would be asking you to do it.” If we could get the health professional and the worried family member to just read Chamberlain’s “basics on cancer,” the road to trying alternative therapies will be far easier for the patient.

When I was involved with the Congressional Technology Assessment’s group asked to study unconventional cancer therapies in the late 1980s, we were deflated by the researchers’ extensive discussion of meditation and visualization as effective alternative therapies compared to using laetrile and vitamin C. Somewhat arrogantly, we thought that we, “the alternative cancer community,” were being blindsided by university biofeedback researchers who were writing tomes on the wonders of relaxation techniques. How could we finally get the privilege of having a Congressional study of unconventional cancer therapies only to have that study seemingly ignore or belittle the great minds of the past century, like Max Gerson, or maverick practitioners, like Donald Kelly? In fact, none of these cancer heroes were ignored, but the study group found tremendous fault with their work compared with the meditation workers who were given nearly impeccable standing. Chamberlain credits the biofeedback community with posing the top four strategies in helping to cure one’s cancer. While some cancer clinics offer work on positive mental attitude, Chamberlain observes that most clinics are little more than chemotherapy profit centers with little incentive to get patients on the right track. “Harnessing the Healing Power of the Mind,” “Loving and Forgiving Yourself and Others,” “Relaxing and Laughing” are the chapter heads for proven therapies that all cancer clinics, orthodox and alternative, should offer at the onset to increase the odds of surviving cancer.

The crème-de-la-crème of the Cancer Recovery Guide unquestionably is the discussion of alternative therapies, which range from the use of intravenous vitamin C to Essiac, from alkalizing the body to detoxification strategies, from Budwig’s use of flaxseed oil mixed in cottage cheese to PolyMVA, and from Rife Machine frequencies to unapproved use of drugs, including Digitalis and Cimetidine. Chamberlain looks at the therapies that have the most background, like Gerson’s diet and colonic enemas, and at the ones that appear to be the least supportable, such as Hulda Clark’s contention that all cancers arise from an intestinal fluke and exposure to propyl alcohol from household and cosmetic product use. With a nice index, the patient and the doctor can have a “15-second” read about a medical alternative right at their fingertips.

I am delighted to have found Chamberlain’s work in such an easy-to-read form. With patient anecdotes and connections to patients’ treatment strategies through their own websites, this book deserves to be placed in the patient library or to be offered for sale from the dispensary.

cancer cure that has been ignored

What would you say if a cure for cancer had been found fifteen years ago and ignored? We’re talking about a cure that was fully backed up by cases of cancer patients receiving the treatment and their cancer visibly disappearing and not reappearing for up to seven years – that is, to the end of the study period. According to an article written in October 2008 by Bill Sardi and Timothy Hubbell, that is exactly the situation in relation to a glyco-protein called Gc-MAF given by once-a-week injections (100 nanograms at a time). Since Gc-MAF is a natural chemical no-one can patent it so no-one can profit from the information so…millions of people continue to die of cancer. The full story can be found at
http://www.thenhf. com/articles/ articles_ 792/articles_ 792.htm

Bill Sardi can be reached at BSardi@aol.com. Timothy Hubbell, a biochemist from Cincinnati, first called attention to this discovery and provided consultation on the biochemistry.

Northern Sprit Radio Interview

My interview with Mark Judkins Helpsmeet of Northern Spirit Radio can be found at the following link

http://www.northernspiritradio.org/index.asp?command=showinfo&showid=475786495886

please  post comments on the Northern Spirit Radio website.
This will have the effect of increasing the rating of the show in
terms of favorites, helping to maintain its visibility on the site.

I always welcome links to my site – feel free to add such a link to
your site or sites you’re connected to – and I especially ask that
the link be accompanied by text including “Northern Spirit Radio”,

Some chemotherapy facts (UK)

http://www.timesonl ine.co.uk/ tol/news/ uk/health/ article5138033. ece
Chemotherapy can do more harm than good, study suggests
David Rose
Doctors have been urged to be more cautious in offering cancer treatment to
terminally-ill patients as chemotherapy can often do more harm than good, a
study suggests.
Patients with incurable cancers were promised much greater access to the
latest drugs which could offer them extra months or years of life by a
Department of Health review last week.
Such medicines are often taken or injected as part of a “cocktail” of
chemotherapy drugs.
But the National Confidential Enquiry into Patient Outcome and Death
(NCEPOD) found that more than four in ten patients who received chemotherapy
towards the end of life suffered potentially fatal effects from the drugs,
and treatment was “inappropriate” in nearly a fifth of cases..
About 300,000 patients now receive chemotherapy in the UK each year, a 60
per cent increase compared to 2004.
But in a study of more than 600 cancer patients who died within 30 days of
receiving treatment, chemotherapy probably caused or hastened death in 27
per cent of cases, the inquiry found.
In only 35 per cent of these cases was care judged to have been good by the
inquiry’s advisors, with 49 per cent having room for improvement and 8 per
cent receiving less than satisfactory care.
More than one fifth of patients were already severely debilitated at the
time the decision to treat with chemotherapy was taken, while that many
could not make an informed consent to treatment, the report said.
Mark Lansdown, surgical oncologist at Leeds General Infirmary, and a
co-author of the report, said that it is usual for patients to suffer some
side-effects following chemotherapy, but that very few patients die as a
consequence.
“The majority of patients in this study were receiving palliative treatment
where the aim is to alleviate symptoms of cancer with the minimum of side
effects,” which represented a small proportion (2 per cent) of all patients
receiving the treatment, he said.
“Yet 43 per cent of all patients in the study suffered significant
treatment-related toxicity.”
The proportion of deaths attributed to chemotherapy “is of particular
concern for the 14 per cent of patients for whom [it] was intended to cure
them of their cancer,” he added.
Co-author Diana Mort, of Velindre NHS Trust, Cardiff, said that treatment
can also result in life-threatening infections or patients may simply die of
their cancer.
“[But] patients must be made aware of the risks and side effects of
chemotherapy as well as the potential benefits. They should be given time to
reflect on their decision and must always be free to change their minds.”
The Government’s national cancer director, Professor Mike Richards, said
that he was “very concerned” by the report’s findings.
The National Chemotherapy Advisory Group will publish a full response to the
NCEPOD report today, “to bring about a step change in the quality and safety
of chemotherapy services for adult patients,” he added.
“I am asking all chemotherapy service providers to consider these reports
urgently and to reassess their own services immediately against the measures
we have set nationally.”
Katherine Murphy, director of the Patients Association, commented: “too many
clinicians have a cavalier attitude to providing information on cancer
outcomes, when they should be doing everything in their power to raise
standards and give full information to their patients.”
Jane Maher, Chief Medical Officer at Macmillan Cancer Support added:
“Doctors and nurses need to be much better at helping patients understand
the pros and cons of such powerful treatments in the last year of life.
“Some patients may not be getting the right information and support before
deciding whether to start chemotherapy and even more importantly, when
enough is enough.
“Something clearly needs to be done – I welcome a prompt response by the National Chemotherapy Advisory Group.”

Libido issues

On the cancercured yahoo discussion group a number of suggestions were made for increasing libido:

Exercise, watermelon, DHEA, Tongkat ali herb, Horny goat weed herb, Tribulus terrestris and Yohimbe bark.  Additional herbs for low libido include Ashwagandha herb, Maca herb, Mucuna Pruriens herb, Muira puama herb, Saw Palmetto and Rhodiola rosea.

In regards to watermelon being a natural viagara. I think that you should tell people that not only does it contain citrulline, which the body converts to arginine, but also that the seed, contain cucurbocitrin, which also dialates blood vessels. Peope should always eat the seeds when they eat watermelon. They should of course be crunched as seeds are designed to go through the intestinal tract unscathed.

Marc Swanepoel writes:

I can vouch from personal experience that the Sutherlandia OPC improves libido and I have had a couple of feedbacks to that effect. Two people I know are using it specifically for that purpose. Whether it is the oleander or the Sutherlandia, I cannot say. Maybe those people who are using the home-made version can shed some more light on this question.

bentonite clay healing cancerous spot

I may have mentioned this before on this list but I had a “hot spot” on
my face and daily applications of hydrated calcium bentonite clay
healed it over a period of about 2 months. I vaguely remember reading
that part of the healing comes from the electro-magnetic charge in the
clay, besides its drawing power and in my own thinking the fact that
perhaps there is magnesium in it that may permeate the skin
transdermally?
I know when I put it on I felt a mild electrical type “tingling” at the
site, that gradually diminished as the healing process progressed.
However it works, it sounds like the life of God is in this substance
for healing.
Blessings, Jill~

Note: The Cancer Survivor’s Bible (2012) is now available – see www.fightingcancer.com

“An excellent up-to-date resource.”

 

Fungal infections such as candida

Nystatin is available as a cream and a powder for external use, and as a tablet and liquid for internal use. It is an intestinal antifungal and is absorbed into the blood to a very small degree. It is therefore useful for intestinal fungal infections like yeast. It has virtually no side effects and can be used with other medication as well as during pregnancy.

Diflucan is a systemic antifungal that enters the bloodstream as well as spinal fluid. It crosses the blood/brain barrier and can be used for deep-seated fungal infections. It  has been reported that some fungi of the Candida species have become resistant to Diflucan. It is not advisable to take it during pregnancy, definitely not while breast-feeding and consult your doctor about using it with statins. It is quite expensive (a reasonably priced source is http://www.medstore .biz/prescriptio ns/diflucan/). People with liver problems should also consult their doctors due to a slight risk of liver toxicity.

Doug Kaufman who wrote a number of books on “The Fungus Link” suggests both the above prescription drugs for initial use with relatively serious fungal infections.

Marc Swanepoel

Many dangers of Tamoxifan

The Big Book: Cancer: The Complete Recovery Guide

The Small Book: Cancer Recovery Guide: 15 Alternative and Complementary Strategies for Restoring Health  –  For more information go to www.fightingcancer.com

“This book tells me everything. Why didn’t my doctor tell me this?” – Rev Bill Newbern

MANY DANGERS OF TAMOXIFAN

Ma

http://www.after-cancer.com is a site dedicated to sorting out the many side-effects of Tamoxifan. It is not widely known that 95% of people taking tamoxifan experience serious impacts on their vision and in a significant number of cases they suffer sight threatening inflammation. So if you’re put on Tamoxifan don’t just put up with eye problems – get them looked at.

Ralph Moss’s excellent newsletter – John Beard, enzymes and cancer

The Big Book: Cancer: The Complete Recovery Guide

The Small Book: Cancer Recovery Guide: 15 Alternative and Complementary Strategies for Restoring Health  –  For more information go to www.fightingcancer.com

“This book tells me everything. Why didn’t my doctor tell me this?” – Rev Bill Newbern

RALPH MOSS & JOHN BEARD

Ralph Moss’s book The Cancer Industry and his newsletter http://www.cancerdecisions.com are important resources: Here is an extract of Moss’s commemoration of the work of John Beard and why pancreatic enzymes are an important approach to cancer:

HAPPY BIRTHDAY TO BEARD-PART II

Two weeks ago I wrote about the special issue on John Beard that Integrative Cancer Therapies is publishing soon. Today, I want to tell you a bit about who John Beard was and why this topic is so important.

To read my previous newsletter on this subject, please click or go to:
http://www.cancerdecisions.com/110208.html

John Beard (1858-1924) was the first individual in history to point to the similarity – he would have said identity — of cancer and the trophoblastic tissue that arises in the early days of pregnancy and eventually forms the placenta. Today, this similarity is a commonplace among embryologists. A 2007 review concluded: “Trophoblast research over the past decades has underlined the striking similarities between the proliferative, migratory and invasive properties of placental cells and those of cancer cells.” ⁱ Some embryologists now refer to trophoblast as a “pseudo-malignancy.” ^ii,iii Beard said as much 100 years ago, although his prior claim on this discovery is not always acknowledged by present-day researchers.

Beard made other outstanding contributions to the life sciences. He was the first to describe the evolution of the nervous system of elasmobranch fishes. He demonstrated the morphological continuity of germ cells in several vertebrate species. He co-discovered the large, transient sensory cells of the spinal cord, still known as Rohon-Beard cells. He was also the first to propose that the corpus luteum was responsible for the inhibition of ovulation during pregnancy and was among the first to describe programmed cell death, or apoptosis. He was the first to describe the thymus as “the parent source” of the lymphoid structures.

Thus, by any reckoning, John Beard deserves to be included among the leading biologists of the late 19^th and early 20^th century. He won a major award from the French Academy of Sciences and was nominated for the Nobel Prize. Today, when Beard is on occasion memorialized, it is for his progressive ideas on the nature of cancer. He has rightly been hailed as a forerunner of the present-day theory of the cancer stem cell (CSC). He is also the father of enzyme therapy. He pointed out that the initiation of fetal pancreatic function coincided with a reduction in the invasiveness of trophoblast, which otherwise might progress to clinical cancer (i.e., choriocarcinoma). Based on the above propositions, he recommended the therapeutic use of pancreatic enzymes in treating cancer and other diseases. This therapy created a worldwide controversy in his day. Although rejected at the time, it prevailed and has entered the world of complementary and alternative medicine (CAM) today. The New York Times predicted as much 100 years ago, when it editorialized on October 9, 1909: “In spite of the present condemnation of trypsin, there is still a large chance that time will tell another story.” And so it has.

In this special issue, I have had the great pleasure of tracing the details of Beard’s life through the twists and turns of historical research. Beard was born in Redding, a suburb of Manchester, England, on Nov. 2, 1858. It was a time of enormous intellectual ferment. Darwin’s Origin of Species came out in the following year. Although Beard’s father and grandfather were workers in the local cotton mills, Beard himself had higher ambitions as well as opportunities. His big break in life was that, after his biological father’s death, his stepfather sent him to an excellent private school to study. He continued his studies locally, then at the University of Manchester with Prof. Arthur Milnes Marshall, in London with Darwin’s disciple, T.H. Huxley, and finally in Freiburg, with Prof. August Weismann. He earned his Ph.D. from the University of Freiburg and later received an honorary Doctor of Science (DSc) from Manchester.

For two decades, Beard mainly studied the elasmobranch fishes (sharks, skates and rays). After spending 20 years in basic embryological research, he published several seminal articles on the cancer problem. How he got from shakes and rays to human cancer is the main subject of my biographical article.

Although some people thought Beard was simply an intellectual fence-jumper, if not an outright cancer crank, there was a logical reason for drawing conclusions about cancer from the study of fishes. Beard detected a separate nervous system in some of these fishes, which emerged and then died away in the course of development. This led him to postulate that there was an “alternation of generations” in animals, even in mammals. Eventually this led him to the theory that the trophoblast was itself a kind of “asexual” growth that accompanied the growth of the sexual embryo. He later identified this trophoblast as identical to cancer, and speculated that pancreatic enzymes would be cancer’s natural antagonist.

I will be writing more on this topic in the near future.